HC Surgical Specialists Dirección

Dirección controles de criterios 2/4

El CEO de HC Surgical Specialists es Sieu Min Heah, nombrado en Sep 2015, tiene una permanencia de 9.17 años. posee directamente un 41.6% de las acciones de la empresa, con un valor de SGD17.60M. La antigüedad media del equipo directivo y de la junta directiva es de 5.6 años y 8.2 años, respectivamente.

Información clave

Sieu Min Heah

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	9.2yrs
Participación del CEO	41.6%
Permanencia media de la dirección	5.6yrs
Promedio de permanencia en la Junta Directiva	8.2yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Sieu Min Heah (60 yo)

9.2yrs

Permanencia

Dr. Sieu Min Heah, MB BCh, FRCSEd (General Surgery), FAMS General Surgery, has been Chief Executive Officer and Executive Director of HC Surgical Specialists Limited since September 1, 2015.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Sieu Min Heah	CEO & Executive Director	9.2yrs	sin datos	41.6% SGD 17.6m
Soo Ling Ong	Chief Financial Officer	8.8yrs	sin datos	sin datos
Josephine Tio Melissa	Chief Operating Officer	2.5yrs	sin datos	sin datos
Kok Hoong Chia	Medical Director & Executive Director	no data	sin datos	22.6% SGD 9.6m
Gary Ng	Head of the Internal Audit	no data	sin datos	sin datos
Hui Theng Lee	Chief Nursing Officer	1.5yrs	sin datos	0.065% SGD 27.5k
Moi Heyang Lin	Joint Company Secretary	no data	sin datos	sin datos
Pei Chan Tang	Joint Company Secretary	no data	sin datos	sin datos

5.6yrs

Permanencia media

60yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 1B1 es experimentado (5.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Sieu Min Heah	CEO & Executive Director	9.2yrs	sin datos	41.6% SGD 17.6m
Kok Hoong Chia	Medical Director & Executive Director	9.2yrs	sin datos	22.6% SGD 9.6m
Seng Soon Ooi	Independent Non-Executive Director	8.2yrs	sin datos	sin datos
Weng Hoe Chong	Independent Non-Executive Chairman	8.2yrs	sin datos	0.11% SGD 46.1k
Chye Lai Lim	Non-Independent Non-Executive Director	8.2yrs	sin datos	0.16% SGD 68.7k

8.2yrs

Permanencia media

60yo

Promedio de edad

Junta con experiencia: La junta directiva de 1B1 se considera experimentada (8.2 años de antigüedad promedio).

HC Surgical Specialists Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

Insufficient new directors

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Insufficient new directors

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: S$0.025 (vs S$0.02 in FY 2023)

HC Surgical Specialists Limited Proposes Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2024, Payable on 25 November 2024

New minor risk - Financial data availability

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

First half 2024 earnings released: EPS: S$0.023 (vs S$0.014 in 1H 2023)

HC Surgical Specialists Limited Declares Interim Dividend for the Financial Year Ending 31 May 2024, Payable on 13 March 2024

HC Surgical Specialists Limited Declares Interim Dividend, Payable on 13 March 2024

Insufficient new directors

Upcoming dividend of S$0.01 per share at 6.3% yield

HC Surgical Specialists Limited Approves A Final Dividend for the Financial Year Ended 31 May 2023

New minor risk - Shareholder dilution

HC Surgical Specialists Limited Proposes Final Dividend for the Financial Year Ended 31 May 2023

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Full year 2023 earnings released: EPS: S$0.019 (vs S$0.043 in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.01 per share at 4.9% yield

HC Surgical Specialists Limited Announces Interim Dividend for the Financial Year Ending 31 May 2023, Payable on 13 March 2023

First half 2023 earnings released

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.012 per share

HC Surgical Specialists Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2022

Now 21% undervalued after recent price drop

HC Surgical Specialists Limited, Annual General Meeting, Sep 27, 2022

Full year 2022 earnings released: EPS: S$0.043 (vs S$0.053 in FY 2021)

HC Surgical Specialists Limited Recommends Final Dividend for the Financial Year Ended May 31, 2022

HC Surgical Specialists Limited Appoints Melissa Josephine Tio @ Melissa Josephine Susantio as Chief Operating Officer, Effective 1 May 2022

Insufficient new directors

HC Surgical Specialists Limited Announces Resignation of Chief Operating Officer, Ouyang Yuxia, Connie, Effective 30 April 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of S$0.023 per share

Upcoming dividend of S$0.023 per share

Full year 2021 earnings released: EPS S$0.053 (vs S$0.027 in FY 2020)

HC Surgical Specialists Limited Announces That the Court of Appeal Dismissed

First half 2021 earnings released: EPS S$0.033

New 90-day high: S$0.42

HC Surgical Specialists Limited (Catalist:1B1) agreed to acquire remaining 30% stake in Julian Ong Endoscopy & Surgery (Pte Ltd).

HC Surgical Specialists Limited (Catalist:1B1) acquired 20% stake in Healthcare Essentials Pte. Ltd. from Lim Chye Lai, Gjan for SGD 0.18 million.

HC Surgical Specialists Provides Cashless and Convenient Healthcare Services to Eligible 1 Customers of Prudential Singapore

New 90-day high: S$0.35

New 90-day high - S$0.34

Full year earnings released - EPS S$0.023

New 90-day low - S$0.29

HC Surgical Specialists Limited completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery (Pte Ltd) from Julian Ong Surgery Pte. Ltd. for $3.8 million.

HC Surgical Specialists Limited (Catalist:1B1) completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery Pte. Ltd from Julian Ong Surgery Pte. Ltd.

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad